Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Search results are limited to:
Abstract Book of the 7th European Myeloma Network Meeting, Prague, 16-18 April 2026
Vol. 111 No. s2
Advanced filters
Search the full archive

B04 | BLOOD-BASED RISK STRATIFICATION OF MYELOMA PATIENTS USING CIRCULATING TUMOR CELLS: RESULTS FROM THE EUROPEAN CTC CONSORTIUM (364 Online Views)

L. Bertamini1, D. Zihala2, I.V. Kostopoulos3, M. D’Agostino4, E. Martín-Sánchez5, J.J. Garcés Latre5, D. Hofste Op Bruinink1, N. Puig6, S. Zweegman7, G. Bertuglia4, P. Malandrakis8, T. Sevcikova2, T. Cupedo1, N.W.C.J. Van De Donk7, M.T. Cedena9, P. Musto10, I. Ntanasis-Stathopoulos8, O. Venglar2, M. Van Duin1, J.J. Lahuerta9, D. Rota Scalabrini11, O. Tsitsilonis3, T. Popkova2, J. Blade12, E. Zamagni13, M. Gavriatopoulou8, L. Muronova2, B. Van Der Holt1|14, P.. Moreau15, M.V. Mateos6, M. Galli16, E. Katodritou17, M. Stork18, A. Belotti19, P. Rousakis3, M. Borsky18, J. Corre20, M. Boccadoro21, M. Dimopoulos8, R. Hajek2, J. San Miguel5, P. Sonneveld1, F. Gay4, E. Terpos8, A. Broijl1, B. Paiva3, T. Jelinek2

1 Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands
2 Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Czech Republic
3 Department of Biology, School of Science, National and Kapodistrian University of Athens, Greece
4 Division of Hematology, AOU Città della Salute e della Scienza di Torino, University of Torino and Department of Molecular Biotechnology and Health Sciences, Italy
5 Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain
6 Hospital Universitario,Salamanca, Spain
7 Department of Hematology, Amsterdam University Medical Center and Vrije Universiteit Amsterdam, the Netherlands
8 Department of Clinical Therapeutics School of Medicine, National and Kapodistrian University of Athens, Greece
9 Hospital Universitario 12 De Octubre, Madrid, Spain
10 Department of Precision and Regenerative Medicine and Ionian Area,"Aldo Moro" University School of Medicine, and Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico, Bari, Italy
11 Multidisciplinary Oncology Outpatient Clinic, Candiolo Cancer Institute, FPO-IRCCS, Torino, Italy
12 Hospital Clínic de Barcelona, Spain
13 IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Italy
14 HOVON Foundation, Rotterdam, the Netherlands
15 Hematology Department, University Hospital Hôtel-Dieu, Nantes, France
16 Hematology and Bone Marrow Transplant Unit, Azienda Socio-Sanitaria Territoriale-Papa Giovanni XXIII, Bergamo, Italy
17 Department of Hematology, Theageneio Cancer Hospital, Thessaloniki, Greece
18 Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Czech Republic
19 Department of Hematology, ASST Spedali Civili di Brescia, Italy
20 Unité de Génomique du Myélome, University Hospital, IUCT-Oncopole, CRCT, Toulouse, France
21 European Myeloma Network, EMN
Circulating Tumor Cells Multiple Myeloma Plasma Cell Egression.

P01 | CIRCULATING TUMOR CELLS IMPROVE RISK STRATIFICATION ACCORDING TO THE SECOND REVISION OF THE INTERNATIONAL STAGING SYSTEM AND THE IMS-IMWG CONSENSUS GENOMIC STAGING IN NDMM PATIENTS. AN ANALYSIS FROM THE EUROPEAN CTC CONSORTIUM (326 Online Views)

M. D’Agostino1, E. Martín-Sánchez2, D. Žihala3|4, I. Kostopoulos5, J.J. Garcés6, N. Puig7, G. Bertuglia1, T. Ševčíková3, T. Cupedo8, M. Van Duin8, J. Keats9, E. Zamagni10|11, P. Moreau12, S. Zweegman13, B. Van Der Holt8|14, D. Hofste Op Bruinink8, E. Dama15, J. Corre16, M. Boccadoro15, M.A. Dimopoulos17|18, R. Hájek3|4, B. Paiva2, P. Sonneveld8|19, A. Broijl8, E. Terpos17, T. Jelínek3|4, J. San-Miguel2, F. Gay1, L. Bertamini8

1 Division of Hematology, AOU Città della Salute e della Scienza di Torino, University of Torino and Department of Molecular Biotechnology and Health Sciences, Italy
2 Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain
3 Department of Hematooncology, University Hospital Ostrava, Czech Republic
4 Department of Hematooncology, Faculty of Medicine, University of Ostrava, Czech Republic
5 School of Science, National and Kapodistrian University of Athens, Greece
6 Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, USA
7 Hospital Universitario Salamanca, Spain
8 Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
9 Clinical Genomics and Therapeutics Division, Translational Genomics Research Institute, Phoenix, USA
10 IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Italy
11 Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Italy
12 Hematology Department, University Hospital Hôtel-Dieu, Nantes, France
13 Department of Hematology, Amsterdam University Medical Center and Vrije Universiteit, The Netherlands
14 HOVON Foundation, Rotterdam, The Netherlands
15 European Myeloma Network, Italy
16 Unité de Génomique du Myélome, University Hospital, IUCT-Oncopole, CRCT, Toulouse, France
17 Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Greece
18 Department of Medicine, Korea University, Seoul, Korea
19 European Myeloma Network, The Netherlands
Circulating Tumor Plasma Cells NDMM European CTC Consortium.
1 - 2 of 2 items
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2026 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online